Recent Publications


Upadhyaya SA, Broniscer A. Chemotherapy of Pediatric High-Grade Gliomas. In: Newton HB, ed. Handbook of Brain Tumor Chemotherapy, Molecular Therapeutics, and Immunotherapy, Second Edition. San Diego: Academic Press, 2018: pp-pp. 557-568 

Broniscer A, Nichols K. Predisposition Syndromes to Central Nervous System Cancers. Brain Tumors in Children. Ed. Amar Gajjar, Frank Smith, Judy Racadio, and Greg Reaman. Springer, 2018: pp-pp.91-116 

Pollack IF, Agnihotri S, Broniscer A. Childhood brain tumors: current management, biological insights and future directions. J Neurosurg in press 

Pinto EM, Hamideh D, Bahrami A, Orr BA, Lin T, Pounds S, Zambetti GP, Pappo AS, Gajjar A, Agnihotri S, Broniscer A. Malignant rhabdoid tumors originating within and outside the central nervous system are clinically and molecularly heterogeneous. Acta Neuropathol 136:315-326, 2018 

Broniscer A, Jia S, Mandrell B, Hamideh D, Huang J, Onar-Thomas A, Gajjar A, Raimondi SC, Tatevossian RG, Stewart CF. Phase 1 trial, pharmacokinetics, and pharmacodynamics of dasatinib combined with crizotinib in children with recurrent or progressive high-grade and diffuse intrinsic pontine glioma. Pediatr Blood Cancer in pres 

Upadhyaya SA, R McGee, Wilky B, Broniscer A. Malignant progression of a peripheral nerve sheath tumor in the setting of rhabdoid tumor predisposition syndrome. Pediatr Blood Cancer in press 

Hoffman LM, Veldhuijzen van Zanten SEM, Colditz N, Baugh J, Chaney B, Hoffmann M, Lane A, Fuller C, Miles L, Hawkins C, Bartels U, Bouffet E, Goldman S, Leary S, Foreman NK, Packer R, Warren KE, Broniscer A, Kieran MW, Minturn J, Comito M, Broxson E, Shih CS, Khatua S, Chintagumpala M, Carret AS, Escorza NY, Hassall T, Ziegler DS, Gottardo N, Dholaria H, Doughman R, Benesch M, Drissi R, Nazarian J, Jabado N, Boddaert N, Varlet P, Giraud G, Castel D, Puget S, Jones C, Hulleman E, Modena P, Giagnacovo M, Antonelli M, Pietsch T, Gielen GH, Jones DTW, Sturm D, Pfister SM, Gerber NU, Grotzer MA, Pfaff E, von Bueren AO, Hargrave D, Solanki GA, Jadrijevic Cvrlje F, Kaspers GJL, Vandertop WP, Grill J, Bailey S, Biassoni V, Massimino M, Calmon R, Sanchez E, Bison B, Warmuth-Metz M, Leach J, Jones B, van Vuurden DG, Kramm CM, Fouladi M. Clinical, radiologic, pathologic, and molecular characteristics of long-term survivors of diffuse intrinsic pontine glioma (DIPG): a collaborative report from the International and European Society for Pediatric Oncology DIPG registries. J Clin Oncol 36:1963-1972, 2018 

Tinkle C, Duncan E, Doubrovin M, Han Y, Li Y, Kim H, Broniscer A, Snyder SE, Merchant TE, Shulkin B. Evaluation of 11C-methionine PET and anatomic MRI associations in diffuse intrinsic pontine glioma. J Nucl Med in press 

Stanley K, Cooper J. Hormone Therapy and Venous Thromboembolism in a Transgender Adolescent. J Pediatric Hematol Oncol 2018 Jan, 40 (1) :e38-e40. PubMed PMID 28945660 

McCormick MC, Siripong N, Cooper JD. Desmopressin stimulation testing: Response to intravenous and intranasal forms. Haemophilia. 2018 mar 26. ePub ahead of print. PubMed PMID 29578274 

Ekambaram P, Lee JL, Hubel NE, Hu D, Yemeni S, Campbell PG, Pollock N, Klei LR, Concel VJ, Delekta PC, Chinnaiyan AM, Tomlins SA, Rhodes DR, Priedigkeit N, Lee AV, Oesterreich S, McAllister-Lucas LM*, Lucas PC*. The CARMA3-Bcl10-MALT1 signalosome drives NF-kB activation and promotes aggressiveness in Angiotensin II Receptor-Postive Breast Cancer (2018) Cancer Res, 78:1225-1240.                               * these authors share senior authorship   

McAuley JR, Freeman T, Ekambaram P, Lucas PC, McAllister-Lucas LM.  CARMA3 is a critical mediator of GPCR and RTK-driven solid tumor pathogenesis (2018) Frontiers in Immunology, in press 

Benneh-Akwasi Kuma A, Owusu-Ansah AT, Ampomah MA, Sey F, Olayemi E. Nouraie M, Ofori-Acquah SF. Prevalence of relative systemic hypertension in adults with sickle cell disease in Ghana. PLoS Once 2018 Jan 4;13(1):30190347. doi.10.1371/ journal.pone.0190347. eCollections 2018 

Dolezal JM, Dash AP, Prochownik EV. Diagnostic and prognostic implications of ribosomal protein transcript expression patterns in human cancers. BMC Cancer. 2018 Mar 12;18(1):275 

Wang H, Dolezal JN,'I, Kulkarni S, Lu J, Mandel J, Alencastro F, Duncan AW, Prochownik EV Myc and ChREBP cooperatively regulate normal and neoplastic hepatocyte proliferation. J. Biol. Chem. 2018.293: 14740-14757 

Gil L, Zhu Y, Lin X, Li Y, Cui K, Prochownik EV, Li Y. Amplification of glyceronephosphate O-acyltransferase and recruitment ofUSP30 stabilize DRPI to promote hepatocarcinogenesis. Cancer Res. 20 18.78:5808-5819. 

Goetzman ES, Prochownik FN. The role fòr myc in coordinating glycolysis, oxidative phosphorylation, glutaminolysis, and fatty acid metabolism in normal and neoplastic tissues. Front Endocrinol (Lausanne). 2018 Apr 12;9: 129. 

Wang H, Lu J, Kulkarni S, Gorka J, Mandel J, Goetzman ES, Prochownik EV. Metabolic and oncogenic adaptations to pyruvate dehydrogenase inactivation (submitted for publication). 

Mandel J, Wang I-I. Normolle IDP, Lucas PC, Benos P, Prochownik EV. Prediction of longterm survival in cancer patients based on expression patterns of 212 or fewer protein-coding transcripts (submitted for publication) 

Wang H, Lu J, Dolezal JM, Kulkarni S, Zhang W, Chen A, Gorka J, Mandel J, Prochownik EV. Inhibition of hepatocellular carcinoma by metabolic normalization (submitted for publication). 

Zhang, Q, Li X, Cui K Prochownik EV, Li Y. The MAP3K13-TRlM25-FBXW7Œ axis affects c-Myc protein stability and tumor progression (submitted for publication). 


Leeper CM, Vissa M, Cooper JD, Malec LM, Gaines BA. Venous thromboembolism in pediatric trauma patients: Ten-year experience and long-term follow-up in a tertiary care center. Pediatr Blood Cancer. 2017;64(8).

Cooper JD, Costello AG, Shaw PH. A comparison of extremity thrombosis rates in adolescent and young adult versus younger pediatric oncology patients at a children’s hospital. J Adolesc Young Adult Oncol. 2017;6(1):62-6.

O’Halloran K, Ritchey AK, Djokic M, Friehling E. Transient juvenile myelomonocytic leukemia in the setting of PTPN11 mutation and Noonan syndrome with secondary development of monosomy 7. Pediatr Blood Cancer. 2017;64(7).

Ou Z, Sherer M, Casey J, Bakos HA, Vitullo K, Hu J, Friehling E, et al. The genomic landscape of PAX5, IKZF1, and CDKN2A/B alterations in B-cell precursor acute lymphoblastic leukemia. Cytogenet Genome Res. 2016;150(3-4):242-52.

Panepinto JA, Paul Scott J, Badaki-Makun O, Darbari DS, Chumpitazi CE, Airewele GE, Ellison AM, Smith-Whitley K, Mahajan P, Sarnaik SA, Charles Casper T, Cook LJ, Leonard J, Hulbert ML, Powell EC, Liem RI, Hickey R, Krishnamurti L, Hillery CA, Brousseau DC; Pediatric Emergency Care Applied Research Network (PECARN). Determining the longitudinal validity and meaningful differences in HRQL of the PedsQLTM Sickle Cell Disease Module. Health Qual Life Outcomes. 2017;15(1):124.

Larson MC, Kara n MS, Hillery CA, Hogg N. Phosphatidylethanolamine is progressively exposed in RBCs during storage. Transfus Med. 2017;27(2):136-41.

Thrane SE, Maurer SH, Cohen SM, May C, Sereika SM. Pediatric palliative care: A five-year retrospective chart review study. J Palliat Med. 2017;20(10):1104-11.

Ivanov AA, Gonzalez-Pecchi V, Khuri LF, Niu Q, Wang Y, Xu U, Bai Y, Mo X Prochownik EV, et al. OncoPPi- informed discovery of mitogen-activated protein kinase 3 as a novel binding partner of c-Myc. Oncogene. 2017. Epub ahead of print.

Zhang Y, Bharathi SS, Rardin MJ, Lu J, Maringer KV, Sims-Lucas S, Prochownik EV, et al. Lysine desuccinylase SIRT5 binds to cardiolipin and regulates the electron transport chain. J Biol Chem. 2017;292(24):10239-49.

Dolezal JM, Wang H, Kulkarni S, Jackson L, Lu J, Ranganathan S, Goetzman ES, Bharathi SS, Beezhold K, Byersdorfer CA, Prochownik EV. Sequential adaptive changes in a c-Myc-driven model of hepatocellular carcinoma. J Biol Chem. 2017;292(24):10068-86.

Landier W, Hageman L, Chen Y, Kornegay N, Evans WE, Bostrom BC, Casillas J, Dickens DS, Angiolillo AL, Lew G, Maloney KW, Mascarenhas L, Ritchey AK, et al. Mercaptopurine ingestion habits, red cell thioguanine nucleotide levels, and relapse risk in children with acute lymphoblastic leukemia: A report from the Children’s Oncology Group study AALL03N1. J Clin Oncol. 2017;35(15):1730-6.

Landier W, Chen Y, Hageman L, Kim H, Bostrom BC, Casillas JN, Dickens DS, Evans WE, Maloney KW, Mascarenhas  L, Ritchey AK, et al. Comparison of self-report and electronic monitoring of 6MP intake in childhood ALL: A Children’s Oncology Group study. Blood. 2017;129(14):1919-26.

Makadia P, Srinath A, Madan-Khetarpal S, McGuire M, Infante E, Zhang J, Felgar RE, Davis AW, Chong HJ, Windreich RM. Aplastic anemia and cytotoxic T lymphocyte antigen-4 haploinsufficiency treated with bone marrow transplantation. J Allergy Clin Immunol Pract. 2017;5(5):1445-7.e2.

Cooper JD, Ritchey AK. Response to treatment and adverse events associated with use of recombinant activated factor VII in children: A retrospective cohort study. Ther Adv Drug Saf. 2017;8(2):51-9.

Goyal RK, Ibrahimova A, Escolar ML, Szabolcs P, Lugt MV, Windreich RM, Weiner DJ. Forced deflation pulmonary function test: A novel method to evaluate lung function in infants and young children. Pediatr Blood Cancer. 2017;64(4).

Proud L, Ritchey AK. Management of type 2b von Willebrand disease in the neonatal period. Pediatr Blood Cancer. 2017;64(1):103-5.

Wang X, Sun CL, Hageman L, Smith K, Singh P, Desai S, Hawkins DS, Hudson MM, Mascarenhas L, Neglia JP, Oeffinger KC, Ritchey AK, Robison LL, Villaluna D, Landier W, Bhatia S. Clinical and genetic risk prediction of subsequent CNS tumors in survivors of childhood cancer: A report from the COG ALTE03N1 study. J Clin Oncol. 2017;35(32):3688-96.

Oparaji JA, Rose F, Okafor D, Howard A, Turner RL, Orabi AI, Byersdorfer C, Mi Q, Ritchey K, Lowe ME, Husain SZ. Risk factors for asparaginase-associated pancreatitis: A systematic review. J Clin Gastroenterol. 2017;51(10):907-13.


Windreich RM, Goyal RK, Joshi R, Kenkre TS, Howrie D, Venkataramanan R. A pilot study of continuous infusion of mycophenolate mofetil for prophylaxis of graft-versus-host disease in pediatric patients. Biol Blood Marrow Transplant. 2016;22(4):682-9.

Boiko JR, Srinath AI, Cooper JD. Portomesenteric venous thrombosis in previously healthy adolescents presenting with subacute abdominal pain. Clin Pediatr. 2016;55(10):975-8.

Owusu-Ansah A, Ihunnah CA, Walker AL, Ofori-Acquah SF. Inflammatory targets of therapy in sickle cell disease. Transl Res. 2016;167(1):281-97.

Tubergen DG, Friehling E, Bleyer A, Ritchey AK. Cancer and benign tumors: the leukemias; acute lymphoblastic leukemia; acute myelogenous leukemia; Down syndrome and acute leukemia and transient myeloproliferative disorder; chronic myelogenous leukemia; juvenile myelomonocytic leukemia; infant leukemia. In: Kligman RM, Behrman RE, Stanton BF, Schor N, St. Geme J, eds. Nelson Textbook of Pediatrics. 20th ed. New York, NY: Elsevier; 2016.

Wandersee NJ, Hillery CA. Red blood cells and the vaso-occlusive process. In: FF Costa, N Conran, eds., Sickle Cell Anemia: From Basic Science to Clinical Practice. Springer; 2016. Barnett M, Maurer S, Wood, G. Pediatric palliative care pilot curriculum: Impact of “pain cards” on resident education. Am J Hosp Palliat Care. 2016;33(9):829-33.

Kelly J, May C, Maurer S. Assessment of the spiritual needs of primary caregivers of children with life-limiting illnesses is valuable yet inconsistently performed in the hospital. J Palliat Med. 2016;19(7):763-6.

Thrane S, Maurer S, Ren D, Danford C, Cohen S. Reiki therapy for symptom management in children receiving palliative care: A pilot study. Am J Hosp Palliat Care. 2016. Epub ahead of print.

Ghosh S, Ihunnah CA, Hazra R, Walker AL, Hansen JM, Archer DR, Owusu-Ansah AT, Ofori-Acquah SF. Nonhematopoietic Nrf2 impedes adult progression of sickle cell anemia in mice. JCI Insight. 2016;1(4). pii: e81090.

Wang H, Lu J, Edmunds LR, Kulkarni S, Dolezal J, Tao J, Ranganathan S, Jackson L, Fromherz M, Stolz DB, Uppala R, Bharathi S, Monga SP, Goetzman ES, Prochownik EV. Coordinated activities of multiple Myc-dependent and Myc-independent biosynthetic pathways in hepatoblastoma. J Biol Chem. 2016;291(51):26241-26251.

Edmunds LR, Otero PA, Sharma L, D’Souza S, Dolezal JM, David S, Lu J, Lamm L, Basantani M, Zhang P, Sipula IJ, Li L, Zeng X, Ding Y, Ding F, Beck
ME, Vockley J, Monga SP, Kershaw EE, O’Doherty RM, Kratz LE, Yates NA, Goetzman EP, Scott D, Duncan AW, Prochownik EV. Abnormal lipid processing but normal long-term repopulation potential of myc-/- hepatocytes. Oncotarget. 2016;7(21):30379-95.

Han H, Chen Y, Cheng L, Prochownik EV, Li Y. MicroRNA-206 impairs c- Myc-driven cancer in a synthetic lethal manner by directly inhibiting MAP3K13. Oncotarget. 2016;7(13):16409-19.

Li Y, Zhu Y, Prochownik EV. MicroRNA- based screens for synthetic lethal interactions with c-Myc. RNA Dis. 2016;3(3). pii: e1330.

Wigton JC, Tersak JM. JAK2+ essential thrombocythemia in a young girl with Budd-Chiara syndrome: Diagnostic and therapeutic considerations when adult disease strikes the young. J Pediat Hematol Oncol. 2016;38(1):70-3.

Vrooman LM, Kirov II, Dreyer ZE, Kelly M, Hijiya N, Brown P, Drachtman RA, Messinger YH, Ritchey AK, et al. Activity and toxicity of intravenous Erwinia asparaginase following allergy to E. coli-derived asparaginase in children and adolescents with acute lymphoblastic leukemia. Pediatr Blood Cancer. 2016;63(2):228-33.

Rosebeck S, Elenitoba-Johnson KSJ, Lim MS, *McAllister-Lucas LM, *Lucas PC. The API2-MALT1 fusion oncoprotein directs a unique program of substrate ubiquitination and proteolysis to promote lymphomagenesis. World J Biol Chem. 2016;7(1):128-37. *co-senior authors.

Ragni MV, DiMichele DM, Hay CM, Malec LM, Seaman CD, Li J, et al. Thrombin generation and bleeding in haemophillia inhibitor patients during immune tolerance induction. Haemophillia. 2016;22(2):240-7.

Malec LM, Moore CG, Bennett CM, Yee DL, Kerlin BA, Witmer CM, et al. Validation study of the composite score to identify von Willebrand disease in children. J Pediatr Hematol Oncol. 2016;38(2):139-42.

Klei LR, Hu D, Panek R, Alfano DN, Bridwell RE, Bailey KM, Oravecz- Wilson KI, Concel VJ, Hess EM, Van Beek M, Delekta PC, Gu S, Watkins SC, Ting AT, Gough PJ, Foley KP, Bertin J, McAllister-Lucas LM, Lucas PC. MALT1 protease activation triggers acute disruption of endothelial barrier integrity via CYLD cleavage. Cell Rep. 2016;17(1):221-32.

Bailey KM, Airik M, Krook MA, Pedersen EA, Lawlor ER. Micro-environmental stress induces src-dependent activation of invadopodia and cell migration in Ewing sarcoma. Neoplasia. 2016;18(8):480-8.

Chang W, Brohl AS, Patidar R, Sindiri S, Shern JF, Wei JS, et al. Multidimensional ClinOmics for precision therapy of children and adolescent young adults with relapsed and refractory cancer: A report from the Center for Cancer Research. Clinical Cancer Research. 2016; 22(15):3810-20.

Bertero A, Pawlowski M, Ortmann D, Snijders K, Yiangou L, Cardoso de Brito M, Brown S, Bernard WG, Cooper JD, et al. Optimized inducible shRNA and CRISPR/Cas9 platforms for in vitro studies of human development using hPSCs. Development. 2016;143(23):4405-18.

Brandow AM, Wandersee NJ, Dasgupta M, Hoffmann RG, Hillery CA, Stucky CL, Panepinto JA. Substance P is increased in patients with sickle cell disease and associated with haemolysis and hydroxycarbamide use. Br J Haematol. 2016;175(2):237-45.

Kazmerski TM, Weiner DJ, Matisko J, Schachner D, Lerch W, May C, Maurer SH. Advance care planning in adolescents with cystic brosis: A quality improvement project. Pediatr Pulmonol. 2016;51(12): 1304-10


Nie Z, Du MQ, McAllister-Lucas LM, Lucas PC, Bailey NG, Hogaboam CM, Lim MS, Elenitoba-Johnson KS. Conversion of the LIMA1 tumor suppressor into an oncogenic LMO-like protein by API2-MALT1 in MALT lymphoma. Nature Communications. 2015;6:5908.

Bhatia S, Landier W, Hageman L, Heeyoung K, Yanjun C, Sun C-L, Kronegay N, Evans WE, Angiolillo AL, Bostrom B, Casillas J, Lew G, Maloney KW, Mascarenhas L, Meza J, Ritchey AK, Termuhlen AM, Carroll, WL, Wong FL, Relling MV. Systemic exposure to thiopurines and risk of relapse. JAMA Oncology. 2015;1(3):287-95.

Ozolek JA, Cohen D, Kool M, Pfister SM, Korshunov A, Bukowinski AJ, Davis AW. Medulloepithelioma with a peculiar clinical presentation, stem cell phenotype, and aberrant DNA-methylation profile. CNS Oncol. 2015;4(4);203-12.

Bukowinski AJ, Burns KC, Parsons K, Perentesis JP, O’Brien MM. Toxicity of cancer therapy in adolescents and young adults. Semin Oncol Nurs. 2015;31(3):216-26.

Buryk MA, Picarsic JL, Creary SE, Shaw PH, Simons JP, Deutsch M, Monaco SE, Nikiforov YE, Witchel SF. Identi cation of unique, heterozygous germline mutation, STK11 (p. F354L), in a child with an encapsulated follicular variant of papillary thyroid carcinoma within six months of completing treatment for neuroblastoma. Pediatr Dev Pathol. 2015;18(4):318-23.

Shaw PH, Reed DR, Yeager N, Zebrack B, Castellino SM, Bleyer A. Adolescent and young adult oncology in the United States: A specialty in its late adolescence. J Pediatr Hematol Oncol. 2015;37(3):161-9.

Raja M, Zverev M, Seipel K, Williams GT, Clarke AR, Shaw PH. Assessment of the in vivo activity of P13K and MEK inhibitors in genetically de ned models of colorectal cancer. Mol Cancer Ther. 2015;14(10):2175-86.

Malec LM, Moore CG, Yabes J, LiJ, Ragni MV. Postpartum haemorrage in women with von Willebrand disease:
An observational study of the Pennsyl- vania Health Care Cost Containment Council (PHC4) database. Haemophillia. 2015;21(5):e442-5.

Ilechie AA, Abokyi S, Owusu-Ansah A, Boadi-Kusi SB, Denkyira AK, Abraham CH. Self-refraction accuracy with adjustable spectacles among children in Ghana. Optom Vis Sci. 2015;92(4):456-63.

Schiff M, Haberberger B, Xia C, Mohsen AW, Goetzman ES, Wang Y, Uppala R, Zhang Y, Karunanidhi A, Prabhu D, Alhardbi H, Prochownik EV, Haack T, Haberle J, Munnich A, Rotig A, Taylor RW, Nichools RD, Kim JJ, Prokisch H, Vockley J. Complex I assembly function and fatty acid oxidation enzyme activity of ACAD9 both contribute to disease severity in ACAD9 deficiency. Hum Mol Genet. 2015;24(11):3238-47.

Jung KY, Wang H, Teriete P, Yap JL, Chen L, Lanning ME, Hu A, Lambert LJ, Holien T, Sundan A, Cosford ND, Prochownik EV, Fletcher S. Perturbation of the c-Myc-Max protein-protein interaction via synthetic a-helix mimetics. J Med Chem. 2015;58(7):3002-24.

Soodgupta D, Pan D, Cui G, Senpan A, Yang Z, Lu L, Weilbaecher KN, Prochownik EV, Lanza GM, Tomasson MH. Small molecule MYC inhibitor conjugated to Intergrin-targeted nanoparticles extends survival in a mouse model of disseminated multiple myeloma. Mol Cancer Ther. 2015;14(6):1286-94.

Wang H, Sharma L, Lu J, Finch P, Fletcher S, Prochownik EV. Structurally diverse c-Myc inhibitors share a common mechanism of action involving ATP depletion. Oncotarget. 2015;6(18):15857-70.

Edmunds LR, Sharma L, Wang H, Kang A, D’Souza S, Lu J, McLaughlin M, Dolezal JM, Gao X, Weintraub ST, Ding Y, Zeng X, Yates N, Prochownik EV. C-Myc and AMPK control cellular energy levels by cooperatively regulating mitochondrial structure and function. PLOS ONE. 2015;10(7):e0134049.

Edmunds LR, Sharma L, Kang A, Lu J, Vockley J, Basu S, Uppala R, Goetzman ES, Beck ME, Scott D, Prochownik EV. c-Myc programs fatty acid metabolism and dictates acetyl-CoA abundance and fate. J Biol Chem. 2015;290(33):20100.

Wang H, Ramakrishnan A, Fletcher S, Prochownik EV. A quantitative, surface plasmon resonance-based approach to evaluating DNA binding by the c-Myc oncoprotein and its disruption by small molecule inhibitors. J Biol Methods. 2015;2(2). pii: e18.

Wang H, Teriete P, Hu A, Raveendra-Panickar D, Pendelton K, Lazo JS, Eiseman J, Hollen T, Misund K, Oliynyk G, Arsenian-Henriksson M, Cosford
ND, Sundan A, Prochownik EV. Direct inhibition of c-Myc Max heterodimers by celastrol and celastrol-inspired triterpenoids. Oncotarget. 2015;6(32):32380-95.

Ho CY, Mobley BC, Gordish-Dressman H, VandenBussche CJ, Mason GE, Bornhorst M, Esbenshade AJ, Tehrani M, Orr BA, LaFrance DR, Devaney JM, Letzer BW, Hofherr SE, Burger PC, Packer RJ.A clinicopathologic study of diencephalic pediatric low-grade gliomas with BRAF V600 mutation. Acta Neuropathol. 2015;130(4):575-85.

Ataga KI, Hinderliter A, Brittain JE, Jones S, Xu H, Cai J, Kim S, Pritchard KA, Hillery CA. Association of pro-inflammatory high-density lipoprotein cholesterol with clinical and laboratory variables in sickle cell disease. Hematology. 2015;20(5):289-96.

Brousseau DC, Scott JP, Badaki-Makun O, Darbari DS, Chumpitazi CE, Airewele GE, Ellison AM, Smith-Whitley K, Mahajan P, Sarnaik SA, Casper TC, Cook LJ, Dean JM, Leonard J, Hulbert ML, Powell EC, Liem RI, Hickey R, Krishnamurti L, Hillery CA, Nimmer M, Panepinto JA. Pediatric Emergency Care Applied Research Network (PECARN). A multicenter randomized controlled trial of intravenous magnesium for sickle cell pain crisis in children. Blood. 2015;126(14):16517.

Yan X, Yan M, Guo Y, Singh G, Chen Y, Yu M, Wang D, Hillery CA, Chan AM. R-Ras regulates murine T cell migration and intercellular adhesion molecule-1 binding. PLoS.One. 2015;10(12):e0145218.

Taylor M, Jakacki R, May C, Howrie D, Maurer S. Ketamine PCA for treatment of end-of-life neuropathic pain in pediatrics. Am J Hosp Palliat Care. 2015;32(8):841:8.

Owusu-Ansah A, Choi SH, Petrosiute A, Letterio JJ, Huang A. Triterpenoid inducers of Nrf2 signaling as potential therapeutic agents in sickle cell disease – a review. Front Med. 2015;9(1):46-56.

Wang H, Teriete P, Hu A, Raveendra- Panickar D, Pendelton K, Lazo JS, Eiseman J, Holien T, Misund K, Oliynyk G, Arsenian-Henriksson M, Cosford ND, Sundan A, Prochownik EV. Direct inhibition of c-Myc-Max heterodimers by celastrol and celastrol-inspired triterpenoids. Oncotarget. 2015;6(32):32380-95.

Ozolek JA, Cohen DE, Kool M, Pfister SM, Korshunov A, Bukowinski AJ, Davis AW. Medulloepithelioma with peculiar clinical presentation, stem cell phenotype, and aberrant DNA methylation profile. CNS Oncology. 2015;4(4):203-12.